Afya Ltd. Reports 15% Increase in First-Half 2025 Revenue, 17% Rise in Net Income, and 16.9% Growth in Basic EPS

Reuters
2025/08/14
Afya Ltd. Reports 15% Increase in First-Half 2025 Revenue, 17% Rise in Net Income, and 16.9% Growth in Basic EPS

Afya Limited, a leading medical education group and medical practice solutions provider in Brazil, announced its financial results for the second quarter and first half of 2025. The company reported a 13.5% year-over-year increase in second-quarter revenue, reaching R$919.4 million. Excluding acquisitions, revenue rose 8.5% to R$879.0 million. For the first half of 2025, revenue grew by 15.0% year-over-year to R$1.855 billion, with a 9.7% increase to R$1.770 billion when excluding acquisitions. The company's adjusted EBITDA for the first half of 2025 was reported at R$892.8 million, marking a 20.4% increase compared to the previous year. The adjusted EBITDA margin expanded by 220 basis points to 48.1%. Excluding acquisitions, the adjusted EBITDA grew by 13.1%, reaching R$839.2 million, with a margin of 47.4%. Net income for the first half of the year increased by 17.0% year-over-year, totaling R$433.6 million. Adjusted net income rose by 9.1%, amounting to R$503.3 million. Afya's basic earnings per share $(EPS)$ also saw a 16.9% increase during the same period. The company reported a strong operating cash conversion ratio of 88.8% and maintained a solid cash position of R$1.099 billion. Afya reaffirmed its full-year 2025 guidance, highlighting its commitment to disciplined execution and strong business fundamentals. The company also reported having approximately 302,000 users within its ecosystem.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Afya Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001292814-25-003049), on August 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10